Search results
Results from the WOW.Com Content Network
Calcitriol is a hormone and the active form of vitamin D, normally made in the kidney. [8] [9] [10] It is also known as 1,25-dihydroxycholecalciferol.It binds to and activates the vitamin D receptor in the nucleus of the cell, which then increases the expression of many genes. [11]
Kidney disease results from kidney damage and subsequent decline in kidney function. ... and nutrients like calcium, ... the kidneys can adversely affect any of these important functions and ...
The kidneys filter 250 mmol of calcium ions a day in pro-urine (or glomerular filtrate), and resorbs 245 mmol, leading to a net average loss in the urine of about 5 mmol/d. The quantity of calcium ions excreted in the urine per day is partially under the influence of the plasma parathyroid hormone (PTH) level - high levels of PTH decreasing the ...
Parathyroid hormone regulates serum calcium through its effects on bone, kidney, and the intestine: [5] In bone, PTH enhances the release of calcium from the large reservoir contained in the bones. [16] Bone resorption is the normal destruction of bone by osteoclasts, which are indirectly stimulated by PTH.
Hypercalciuria is the condition of elevated calcium in the urine. Chronic hypercalciuria may lead to impairment of renal function, nephrocalcinosis, and chronic kidney disease. Patients with hypercalciuria have kidneys that excrete higher levels of calcium than normal, for which there are many possible causes. Calcium may come from one of two ...
The term nephrocalcinosis is used to describe the deposition of both calcium oxalate and calcium phosphate. [1] It may cause acute kidney injury. It is now more commonly used to describe diffuse, fine, renal parenchymal calcification in radiology. [2] It is caused by multiple different conditions and is determined by progressive kidney dysfunction.
IH can predispose individuals to osteopenia or osteoporosis, [2] and affects the entire body. IH arises due to faulty calcium homeostasis, a closely monitored process, where slight deviations in calcium transport in the intestines, blood, and bone can lead to excessive calcium excretion, bone mineral density loss, or kidney stone formation.
Denosumab caused normalization of calcium levels in 70% in those with hypercalcemia of malignancy. [22] Calcitonin blocks bone resorption by inhibiting osteoclasts and also increases urinary calcium excretion by the kidneys. [22] Usually used in life-threatening hypercalcaemia along with rehydration, diuresis, and bisphosphonates